OmniAb (OABI) Capital Expenditures Growth (3y) (2025 - 2026)
OmniAb (OABI) Capital Expenditures Growth (3y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 16.27% |
| 10 | OmniAb | 259.70 Mn | 210.62 Mn | 14.41 Mn | 52.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.91% |
| Dec 31, 2025 | -24.90% |
| Sep 30, 2025 | 45.11% |
| Jun 30, 2025 | -46.71% |
| Mar 31, 2025 | -56.34% |